l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Neurobiology of Disease Year : 2008

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

Barbara Picconi
  • Function : Author
Vincent Paillé
Institut des Maladies de l'Appareil Digestif [Nantes]
Fondazione Santa Lucia [IRCCS]
CV
Veronica Ghiglieri
  • Function : Author
Vincenza Bagetta
  • Function : Author
Ilaria Barone
  • Function : Author
Hanna Lindgren
  • Function : Author
Giorgio Bernardi
  • Function : Author
M. Angela Cenci
  • Function : Author
Paolo Calabresi
  • Function : Author

Domains

Psychology and behavior Cognitive Sciences Neurobiology Neurons and Cognition [q-bio.NC] Human health and pathology Biochemistry, Molecular Biology Food and Nutrition Life Sciences [q-bio] Neuroscience

Vincent Paillé  : Connect in order to contact the contributor

https://hal.inrae.fr/hal-03426423

Submitted on : Friday, November 12, 2021-11:36:12 AM

Last modification on : Tuesday, November 16, 2021-3:20:42 AM

Consult on ISTEX platform

Dates and versions

hal-03426423 , version 1 (12-11-2021)

Identifiers

Cite

Barbara Picconi, Vincent Paillé, Veronica Ghiglieri, Vincenza Bagetta, Ilaria Barone, et al.. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiology of Disease, 2008, 29 (2), pp.327-335. ⟨10.1016/j.nbd.2007.10.001⟩. ⟨hal-03426423⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INRAE
6 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More